2024
Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach.
Regan C, Scierka L, Dardik A, Tonnessen B, Iyad Ochoa Chaar C, Ionescu C, Aboian E, Cardella J, Nassiri N, Guzman R, Attaran R, Nagpal S, Shah S, Smolderen K, Mena-Hurtado C. Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. Vascular 2024, 17085381241246318. PMID: 38669051, DOI: 10.1177/17085381241246318.Peer-Reviewed Original ResearchDual antiplatelet therapyPeripheral arterial diseaseCYP2C19 testingCYP2C19 mutationsHeterogeneity of treatment effectsPeripheral vascular interventionsConsensus statementKnowledge questionsAntiplatelet therapyGenetic testingVascular surgeryAcademic health systemBarriers to implementationInterquartile rangeCYP2C19 genotype testingVascular diseaseInterventional cardiologyModified Delphi methodPatient's metabolic statusManagement of patientsCritical limb ischemiaPerceived barriersPeripheral vascular diseaseArterial vascular diseaseClinician perspectives
2019
PATTERNS AND PREDICTORS OF REFERRAL FOR INVASIVE MANAGEMENT OF PERIPHERAL ARTERIAL DISEASE IN THE UNITED STATES: INSIGHTS FROM THE PORTRAIT REGISTRY
Jelani Q, Shah S, Yuanyuan T, Spertus J, Smolderen K, Aronow H, Paredes M, Attaran R, Regan C, Mena-Hurtado C. PATTERNS AND PREDICTORS OF REFERRAL FOR INVASIVE MANAGEMENT OF PERIPHERAL ARTERIAL DISEASE IN THE UNITED STATES: INSIGHTS FROM THE PORTRAIT REGISTRY. Journal Of The American College Of Cardiology 2019, 73: 2044. DOI: 10.1016/s0735-1097(19)32650-6.Peer-Reviewed Original Research